DRUG INTERACTIONS AND POLYPRAGMASY IN A PHYSICIAN’S PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Drug interactions and polypragmasy are important risk factors of adverse reactions in clinical practice. The paper presents the types and mechanisms of drug interaction and the examples of clinically relevant drug-food interactions. It outlines ways to prevent the clinically significant interactions and to control polypragmasy, including those using IT technologies.

Full Text

Restricted Access

References

  1. Арсланбекова С.М., Смирнов В.А., Казаков Р.Е. и др. Особенности влияния генетических факторов на режим дозирования варфарина и активность основного фермента его биотрансформации CYP2C9, оцененную по концентрации метаболита лозартана Е-3174 в моче, у пациентов кардиохирургического профиля. URL: http://www.rspor.ru/index.php?mod1=congress/rspor_ congress_2011_ppt
  2. Василенко В.В. Критерии Бирса. URL http:// http://www.mif-ua.com/ archive/article_print/14054
  3. Деримедведь Л.В., Перцев И.М., Шуванова Е.В. и др. Взаимодействие лекарств и эффективность фармакотерапии. Под ред. И.М. Перцева / Мегаполис, 2001; 784 с.
  4. Кукес В.Г. Клиническая фармакология. Взаимодействие лекарственных средств / М.: ГЭОТАР-Мед.- 2008; 151-85.
  5. Отделенов В.А., Новакова А.Н., Карасев А.В. и др. Оценка частоты потенциально значимых межлекарственных взаимодействий у больных с полипрагмазией в многопрофильном стационаре // Клин. фармакол. и тер. - 2012; 5: 81-5.
  6. Приказ Министерства здравоохранения и социального развития Российской Федерации от 22 ноября 2010 г. №1022н «Об утверждении Порядка оказания медицинской помощи населению по профилю «Клиническая фармакология»». URL: http://www.rg.ru/2010/12/31/farmakologia-dok.html
  7. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults // J. Am. Geriatr. Soc. - 2012; 60 (4): 616-31.
  8. Ansell J., McDonough M., Zhao Y. et al. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial // J. Clin. Pharmacol. - 2009; 49 (7): 824-30.
  9. Astrand B. Avoiding drug-drug interactions // Chemotherapy. - 2009; 55 (4): 215-20.
  10. Davies E., Green C., Taylor S. et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes // PLoS One. - 2009; 4 (2): 4439.
  11. Garfinkel D., Zur-Gil S., Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people // Isr/ Med/ Assoc/ J. - 2007; 9 (6): 430-4.
  12. Griffiths A., Beddall A., Pegler S. Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin // J. R. Soc. Prom. Health. - 2008; 128 (6): 324-6.
  13. Hu S., Capezuti E., Foust J. et al. Medication discrepancy and potentially inappropriate medication in older Chinese-American home-care patients after hospital discharge // Am. J. Geriatr. Pharmacother. - 2012; 10 (5): 284-95.
  14. Li Z., Seeram N., Carpenter C. et al. Cranberry does not affect prothrombin time in male subjects on warfarin // J. Am. Diet. Assoc. - 2006; 106 (12): 2057-61.
  15. Magro L., Moretti U., Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions // Exp. Opin. Drug. Saf. - 2012; 11 (1): 83-94.
  16. Mergenhagen K., Sherman O. Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin // Am. J. Health. Syst. Pharm. - 2008; 65 (22): 2113-6.
  17. Mohammed Abdul M., Jiang X., Williams K. et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects // Br. J. Pharmacol. - 2008; 154 (8): 1691-700.
  18. Paeng C., Sprague M., Jackevicius C. Interaction between warfarin and cranberry juice // Clin. Ther. - 2007; 29 (8): 1730-35.
  19. Ruggiero C., Dell'Aquila G. et al. ULISSE Study Group. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project // Drugs. Aging. - 2010; 27 (9): 747-58.
  20. Saverno K., Hines L., Warholak T. et al. Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions // J. Am. Med. Inform. Assoc. - 2011; 18 (1): 32-7.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies